LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophageal cancer and prognosis

Oncogene

Volumn 34, Issue 36, 2015, Pages 4723-4734

  Wu, H ^a   Zheng, J ^a   Deng, J ^a   Zhang, L ^b   Li, N ^a   Li, W ^a   Li, F ^a   Lu, J ^c   Zhou, Y ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; LONG UNTRANSLATED RNA; TRANSCRIPTION FACTOR RUNX1; RUNX1 PROTEIN, HUMAN;

ADULT; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL MIGRATION; CELL PROLIFERATION; CHINA; CHINESE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR INVASION; AGED; ANIMAL; BIOSYNTHESIS; DRUG SCREENING; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ALTERNATIVE SPLICING; ANIMALS; CARCINOMA, SQUAMOUS CELL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICE; MIDDLE AGED; PROGNOSIS; RNA, LONG NONCODING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84940957571     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.400     Document Type: Article

References (45)

1. Szumilo J. Epidemiology and risk factors of the esophageal squamous cell carcinoma. Pol Merkur Lekarski 2009; 26: 82-85.
2. Wu C, Li D, Jia W, Hu Z, Zhou Y, Yu D et al. Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. Nat Genet 2013; 45: 632-638.
3. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M et al. Genetic alterations in esophageal cancer. Surg Today 2005; 35: 7-18.
4. Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, Kawaguchi T et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 2009; 137: 1768-1775.
5. Hu N, Wang C, Hu Y, Yang HH, Giffen C, Tang ZZ et al. Genome-wide association study in esophageal cancer using GeneChip mapping 10 K array. Cancer Res 2005. 65. 2542-2546.
6. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010; 42: 759-763.
7. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42: 764-767.
8. Jin G, Ma H, Wu C, Dai J, Zhang R, Shi Y et al. Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese. Am J Hum Genet 2012; 91: 928-934.
9. Yang HH, Hu N, Taylor PR, Lee MP. Whole genome-wide association study using affymetrix SNP chip: a two-stage sequential selection method to identify genes that increase the risk of developing complex diseases. Methods Mol Med 2008. 141. 23-35.
10. Yamabuki T, Daigo Y, Kato T, Hayama S, Tsunoda T, Miyamoto M et al. Genomewide gene expression profile analysis of esophageal squamous cell carcinomas. Int J Oncol 2006; 28: 1375-1384.
11. Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet 2011; 43: 679-684.
12. Wu C, Kraft P, Zhai K, Chang J, Wang Z, Li Y et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 2012; 44: 1090-1097.
13. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008; 118: 1590-1605.
14. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447: 799-816.
15. Dinger ME, Amaral PP, Mercer TR, Mattick JS. Pervasive transcription of the eukaryotic genome: functional indices and conceptual implications. Brief Funct Genomic Proteomic 2009; 8: 407-423.
16. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629-641.
17. Kapranov P St, Laurent G, Raz T, Ozsolak F, Reynolds CP, Sorensen PH et al. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol 2010; 8: 149.
18. Willingham AT, Orth AP, Batalov S, Peters EC, Wen BG, Aza-Blanc P et al. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 2005; 309: 1570-1573.
19. Martianov I, Ramadass A, Serra Barros A, Chow N, Akoulitchev A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007; 445: 666-670.
20. Wang X, Arai S, Song X, Reichart D, Du K, Pascual G et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008; 454: 126-130.
21. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A codingindependent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465: 1033-1038.
22. Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet 2010; 19: R152-R161.
23. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 10: 38.
24. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 391-407.
25. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003; 22: 8031-8041.
26. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010. 329. 689-693.
27. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38: 662-674.
28. Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 2011; 147: 1537-1550.
29. Sun M, Liu XH, Wang KM, Nie FQ, Kong R, Yang JS et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer 2014; 13: 68.
30. Liu X, Zhang Q, Zhang DE, Zhou C, Xing H, Tian Z et al. Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis. Leukemia 2009; 23: 739-745.
31. Guo H, Ma O, Speck NA, Friedman AD. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis. Blood 2012; 119: 4408-4418.
32. Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ et al. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 2001; 8: 817-828.
33. Sato A, Yamada N, Ogawa Y, Ikegami M. CCAAT/enhancer-binding protein-alpha suppresses lung tumor development in mice through the p38alpha MAP kinase pathway. PLoS One 2013; 8: e57013.
34. Girard N, Tremblay M, Humbert M, Grondin B, Haman A, Labrecque J et al. RARalpha-PLZF oncogene inhibits C/EBPalpha function in myeloid cells. Proc Natl Acad Sci USA 2013; 110: 13522-13527.
35. Chimge NO, Frenkel B. The RUNX family in breast cancer: relationships with estrogen signaling. Oncogene 2013; 32: 2121-2130.
36. Scheitz CJ, Lee TS, McDermitt DJ, Tumbar T. Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer. EMBO J 2012; 31: 4124-4139.
37. Dulak AM, Schumacher SE, van Lieshout J, Imamura Y, Fox C, Shim B et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res 2012; 72: 4383-4393.
38. Ito Y. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 2004. 23. 4198-4208.
39. Tsuzuki S, Hong D, Gupta R, Matsuo K, Seto M, Enver T. Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1. PLoS Med 2007. 4. e172.
40. Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009; 10: 741-754.
41. Luco RF, Misteli T. More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation. Curr Opin Genet Dev 2011; 21: 366-372.
42. Sun S, Zhang Z, Sinha R, Karni R, Krainer AR. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control. Nat Struct Mol Biol 2010; 17: 306-312.
43. Han H, Irimia M, Ross PJ, Sung HK, Alipanahi B, David L et al. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature 2013; 498: 241-245.
44. Kumar M, Witt B, Knippschild U, Koch S, Meena JK, Heinlein C et al. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis. Int J Cancer 2013; 132: 2032-2043.
45. Muller C, Calkhoven CF, Sha X, Leutz A. The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest. J Biol Chem 2004; 279: 7353-7358.